CIBC Bancorp USA’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
CIBC Bancorp USA's GH Position: Q3 2026 in Review
CIBC Bancorp USA increased its Guardant Health (GH) stake by 1,087% in Q3 2026, buying an estimated $15.2M and bringing the position to 101,839 shares worth $18.2M. The position accounts for 0.02% of the portfolio, ranked #421.
CIBC Bancorp USA first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- CIBC Bancorp USA held 101,839 shares of Guardant Health worth $18.2M as of Q3 2026.
- CIBC Bancorp USA bought 93,261 Guardant Health shares in Q3 2026, an estimated $15.2M.
- Guardant Health made up 0.02% of CIBC Bancorp USA's portfolio in Q3 2026, its #421 holding.
- CIBC Bancorp USA first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
- 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.